Literature DB >> 9348191

Transforming growth factor-beta1 inhibits membrane association of protein kinase C alpha in a human prostate cancer cell line, PC3.

M L Lamm1, D D Long, S M Goodwin, C Lee.   

Abstract

The postreceptor signaling pathway(s) that mediates the effects of transforming growth factor-beta1 (TGF-beta1) is incompletely understood. The present study investigated the involvement of protein kinase C (PKC) in the growth-inhibitory action of TGF-beta1 in PC3, a human prostate cancer cell line. PKC alpha, the only conventional PKC isoform detected in PC3 cells, appeared to be constitutively active based on its presence in both Triton-soluble membrane fraction and cytosol. However, levels of membrane-associated PKC alpha were decreased by a growth-inhibitory dose of TGF-beta1. The response to TGF-beta1 was rapid (within 5 min), time dependent, isoform specific, and occurred without apparent changes in levels of total PKC alpha protein. TGF-beta1 also decreased the levels of membrane-associated PKC activity coincident with its inhibitory effect on PKC alpha's membrane association. Inhibition of PKC activity appeared to be associated with growth inhibition in PC3 cells, because chelerythrine (a specific PKC inhibitor) likewise decreased cell proliferation. Taken together, our data suggest that inhibition of PKC activity, at least in part due to inactivation of PKC alpha, is an early event associated with TGF-beta1 postreceptor signaling that might mediate suppression of cell proliferation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9348191     DOI: 10.1210/endo.138.11.5531

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  10 in total

1.  [Transforming growth factor β in prostate cancer: cellular effects and basic molecular mechanisms].

Authors:  M B Stope; C Rönnau; T Schubert; D Staar; J Bradl; P Ziegler; A Streitbörger; N Kroeger; U Zimmermann; R Walther; M Burchardt; C Börgermann
Journal:  Urologe A       Date:  2013-03       Impact factor: 0.639

2.  Differential sensitization of different prostate cancer cells to apoptosis.

Authors:  Jinjin Guo; Tongbo Zhu; Lihua Chen; Takashi Nishioka; Takanori Tsuji; Zhi-Xiong J Xiao; Chang Yan Chen
Journal:  Genes Cancer       Date:  2010-08

3.  WJ9708012 exerts anticancer activity through PKC-α related crosstalk of mitochondrial and endoplasmic reticulum stresses in human hormone-refractory prostate cancer cells.

Authors:  Ting-chun Kuo; Wei-jan Huang; Jih-hwa Guh
Journal:  Acta Pharmacol Sin       Date:  2010-12-06       Impact factor: 6.150

4.  Missing Selectivity of Targeted 4β-Phorbol Prodrugs Expected to be Potential Chemotherapeutics.

Authors:  Ilari Tarvainen; Tomáš Zimmermann; Pia Heinonen; Maria Helena Jäntti; Jari Yli-Kauhaluoma; Virpi Talman; Henrik Franzyk; Raimo K Tuominen; Søren Brøgger Christensen
Journal:  ACS Med Chem Lett       Date:  2019-12-23       Impact factor: 4.345

5.  PKCalpha-induced drug resistance in pancreatic cancer cells is associated with transforming growth factor-beta1.

Authors:  Ying Chen; Guanzhen Yu; Danghui Yu; Minghua Zhu
Journal:  J Exp Clin Cancer Res       Date:  2010-08-05

6.  Locally generated methylseleninic acid induces specific inactivation of protein kinase C isoenzymes: relevance to selenium-induced apoptosis in prostate cancer cells.

Authors:  Usha Gundimeda; Jason Eric Schiffman; Divya Chhabra; Jourdan Wong; Adela Wu; Rayudu Gopalakrishna
Journal:  J Biol Chem       Date:  2008-10-15       Impact factor: 5.157

7.  Ellagic acid checks lymphoma promotion via regulation of PKC signaling pathway.

Authors:  Sudha Mishra; Manjula Vinayak
Journal:  Mol Biol Rep       Date:  2012-10-31       Impact factor: 2.316

8.  Protein kinase C isoenzyme patterns characteristically modulated in early prostate cancer.

Authors:  P Cornford; J Evans; A Dodson; K Parsons; A Woolfenden; J Neoptolemos; C S Foster
Journal:  Am J Pathol       Date:  1999-01       Impact factor: 4.307

9.  Human prostate cell lines from normal and tumourigenic epithelia differ in the pattern and control of choline lipid headgroups released into the medium on stimulation of protein kinase C.

Authors:  M Rumsby; J Schmitt; M Sharrard; G Rodrigues; M Stower; N Maitland
Journal:  Br J Cancer       Date:  2011-01-25       Impact factor: 7.640

10.  Screening key microRNAs for castration-resistant prostate cancer based on miRNA/mRNA functional synergistic network.

Authors:  Jin Zhu; Sugui Wang; Wenyu Zhang; Junyi Qiu; Yuxi Shan; Dongrong Yang; Bairong Shen
Journal:  Oncotarget       Date:  2015-12-22
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.